A new trading day began on Monday, with Q32 Bio Inc (NASDAQ: QTTB) stock price down -10.03% from the previous day of trading, before settling in for the closing price of $3.59. QTTB’s price has ranged from $3.02 to $53.79 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 199.24% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 25.44%. With a float of $4.63 million, this company’s outstanding shares have now reached $12.14 million.
In an organization with 7 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Q32 Bio Inc (QTTB) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Q32 Bio Inc is 61.97%, while institutional ownership is 31.78%. The most recent insider transaction that took place on Mar 25 ’24, was worth 6,413. In this transaction Director of this company sold 265 shares at a rate of $24.20, taking the stock ownership to the 7,983 shares. Before that another transaction happened on Mar 25 ’24, when Company’s insider sold 268 for $24.21, making the entire transaction worth $6,488. This insider now owns 2,596 shares in total.
Q32 Bio Inc (QTTB) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.40% during the next five years compared to -0.07% drop over the previous five years of trading.
Q32 Bio Inc (NASDAQ: QTTB) Trading Performance Indicators
Here are Q32 Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -14.21, a number that is poised to hit -1.53 in the next quarter and is forecasted to reach -4.14 in one year’s time.
Technical Analysis of Q32 Bio Inc (QTTB)
Let’s dig in a bit further. During the last 5-days, its volume was 0.68 million. That was better than the volume of 0.12 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 2.56%. Additionally, its Average True Range was 2.76.
During the past 100 days, Q32 Bio Inc’s (QTTB) raw stochastic average was set at 0.41%, which indicates a significant decrease from 0.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 576.52% in the past 14 days, which was higher than the 242.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.05, while its 200-day Moving Average is $30.47. However, in the short run, Q32 Bio Inc’s stock first resistance to watch stands at $3.59. Second resistance stands at $3.94. The third major resistance level sits at $4.16. If the price goes on to break the first support level at $3.02, it is likely to go to the next support level at $2.80. Assuming the price breaks the second support level, the third support level stands at $2.45.
Q32 Bio Inc (NASDAQ: QTTB) Key Stats
With a market capitalization of 39.34 million, the company has a total of 12,181K Shares Outstanding. Currently, annual sales are 1,160 K while annual income is -112,960 K. The company’s previous quarter sales were 0 K while its latest quarter income was -17,600 K.
